Traussnigg, S., Schattenberg, J. M., Demir, M., Wiegand, J., Geier, A., Teuber, G., Hofmann, W. P., Kremer, A. E., Spreda, F., Kluwe, J., Petersen, J., Boettler, T., Rainer, F., Halilbasic, E., Greinwald, R., Pröls, M., Manns, M. P., Fickert, P., Trauner, M., & , (2019). norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. Lancet gastroenterology and hepatology, 4, 781–793. http://access.bl.uk/ark:/81055/vdc_100091291216.0x000002